1887

Abstract

Introduction. Cryptococcosis in immunocompetent adults is a rare disease in Europe, mostly induced by members of the Cryptococcus gattii species complex. The diagnosis can be challenging due to its rarity, unspecific symptoms and long symptomless latency.

Case presentation. A 49-year-old woman with a three weeks history of headache was admitted to the hospital due to discrete ataxia and impaired vision. Cranial magnetic resonance imaging (MRI) showed a contrast-enhancing mass in the cerebellum. Further investigations detected a slight leukocytosis and a single subpleural nodule in the right inferior lung lobe. The cerebral lesion was surgically removed, and a direct frozen section only showed an unspecific inflammation. In the course of her admission she developed non-treatable cerebral edema and died ten days after surgical intervention. Histopathological examination of the surgical specimen and postmortem evaluation of the lung and the cerebrum demonstrated fungal elements. Molecular identification of the fungal elements in formalin-fixed paraffin-embedded tissue lead to the diagnosis of cryptococcosis induced by C. gattii sensu lato. Molecular genetic analysis identified the involved cryptococcal species as genotype AFLP6/VGII, recently described as Cryptococcus deuterogattii, which is known to be endemic to the west-coast of Canada and the USA. Additional heteroanamnestic information revealed that she had spent her holidays on Vancouver Island, Canada, two years before disease onset, indicating that infection during this stay seems to be plausible.

Conclusion. Cryptococcosis due to C. deuterogattii is a rarely encountered fungal disease in Europe, not particularly associated with immunodeficiency, and infection is likely to be contracted in endemic areas. Due to its rarity, long symptomless latency, unspecific symptoms and misleading radiological features the diagnosis can be challenging. Physicians need to be aware of this differential diagnosis in immunocompetent patients, as early adequate therapy can be lifesaving.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.005168
2018-10-23
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/5/10/jmmcr005168.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.005168&mimeType=html&fmt=ahah

References

  1. Hagen F, Colom MF, Swinne D, Tintelnot K, Iatta R et al. Autochthonous and dormant Cryptococcus gattii infections in Europe. Emerg Infect Dis 2012; 18:1618–1624 [View Article][PubMed]
    [Google Scholar]
  2. Galanis E, MacDougall L, Kidd S, Morshed M. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007. Emerg Infect Dis 2010; 16:251–257 [View Article][PubMed]
    [Google Scholar]
  3. Bovers M, Hagen F, Kuramae EE, Diaz MR, Spanjaard L et al. Unique hybrids between the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii. FEMS Yeast Res 2006; 6:599–607 [View Article][PubMed]
    [Google Scholar]
  4. Chen SC, Slavin MA, Heath CH, Playford EG, Byth K et al. Clinical manifestations of Cryptococcus gattii infection: determinants of neurological sequelae and death. Clin Infect Dis 2012; 55:789–798 [View Article][PubMed]
    [Google Scholar]
  5. Yu JQ, Tang KJ, Xu BL, Xie CM, Light RW. Pulmonary cryptococcosis in non-AIDS patients. Braz J Infect Dis 2012; 16:531–539 [View Article][PubMed]
    [Google Scholar]
  6. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis 2010; 50:291–322 [View Article][PubMed]
    [Google Scholar]
  7. Hagen F, van Assen S, Luijckx GJ, Boekhout T, Kampinga GA. Activated dormant Cryptococcus gattii infection in a Dutch tourist who visited Vancouver Island (Canada): a molecular epidemiological approach. Med Mycol 2010; 48:528–531 [View Article][PubMed]
    [Google Scholar]
  8. MacDougall L, Fyfe M. Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J Clin Microbiol 2006; 44:1851–1852 [View Article][PubMed]
    [Google Scholar]
  9. Hagen F, Khayhan K, Theelen B, Kolecka A, Polacheck I et al. Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex. Fungal Genet Biol 2015; 78:16–48 [View Article][PubMed]
    [Google Scholar]
  10. Byrnes EJ, Li W, Lewit Y, Ma H, Voelz K et al. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 2010; 6:e1000850 [View Article][PubMed]
    [Google Scholar]
  11. Hagen F, Ceresini PC, Polacheck I, Ma H, van Nieuwerburgh F et al. Ancient dispersal of the human fungal pathogen Cryptococcus gattii from the Amazon rainforest. PLoS One 2013; 8:e71148 [View Article][PubMed]
    [Google Scholar]
  12. Hoang LM, Maguire JA, Doyle P, Fyfe M, Roscoe DL. Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997–2002): epidemiology, microbiology and histopathology. J Med Microbiol 2004; 53:935–940 [View Article][PubMed]
    [Google Scholar]
  13. Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004; 101:17258–17263 [View Article][PubMed]
    [Google Scholar]
  14. Smith IM, Stephan C, Hogardt M, Klawe C, Tintelnot K et al. Cryptococcosis due to Cryptococcus gattii in Germany from 2004–2013. Int J Med Microbiol 2015; 305:719–723 [View Article][PubMed]
    [Google Scholar]
  15. Cogliati M, D'Amicis R, Zani A, Montagna MT, Caggiano G et al. Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin. FEMS Yeast Res 2016; 16:fow045 [View Article][PubMed]
    [Google Scholar]
  16. Rickerts V, Khot PD, Myerson D, Ko DL, Lambrecht E et al. Comparison of quantitative real time PCR with sequencing and ribosomal RNA-FISH for the identification of fungi in formalin fixed, paraffin-embedded tissue specimens. BMC Infect Dis 2011; 11:202 [View Article][PubMed]
    [Google Scholar]
  17. Chen S, Sorrell T, Nimmo G, Speed B, Currie B et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis 2000; 31:499–508 [View Article][PubMed]
    [Google Scholar]
  18. Mischnik A, Klein S, Tintelnot K, Zimmermann S, Rickerts V. Kryptokokkose: kasuistiken, epidemiologie und therapiestrategien. DMW - Dtsch Med Wochenschr 2013; 138:1533–1538
    [Google Scholar]
  19. Chen SC, Meyer W, Sorrell TC. Cryptococcus gattii infections. Clin Microbiol Rev 2014; 27:980–1024 [View Article][PubMed]
    [Google Scholar]
  20. Bartlett KH, Cheng PY, Duncan C, Galanis E, Hoang L et al. A decade of experience: Cryptococcus gattii in British Columbia. Mycopathologia 2012; 173:311–319 [View Article][PubMed]
    [Google Scholar]
  21. Hagen F, Illnait-Zaragozi MT, Bartlett KH, Swinne D, Geertsen E et al. In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrob Agents Chemother 2010; 54:5139–5145 [View Article][PubMed]
    [Google Scholar]
  22. Harris JR, Lockhart SR, Sondermeyer G, Vugia DJ, Crist MB et al. Cryptococcus gattii infections in multiple states outside the US Pacific Northwest. Emerg Infect Dis 2013; 19:1621–1627 [View Article][PubMed]
    [Google Scholar]
  23. Dora JM, Kelbert S, Deutschendorf C, Cunha VS, Aquino VR et al. Cutaneous cryptococccosis due to Cryptococcus gattii in immunocompetent hosts: case report and review. Mycopathologia 2006; 161:235–238 [View Article][PubMed]
    [Google Scholar]
  24. Ulett KB, Cockburn JW, Jeffree R, Woods ML. Cerebral cryptococcoma mimicking glioblastoma. BMJ Case Rep 2017; 2017:bcr2016218824 [View Article][PubMed]
    [Google Scholar]
  25. Oliveira FM, Severo CB, Guazzelli LS, Severo LC. Cryptococcus gattii fungemia: report of a case with lung and brain lesions mimicking radiological features of malignancy. Rev Inst Med Trop Sao Paulo 2007; 49:263–265 [View Article][PubMed]
    [Google Scholar]
  26. Cogliati M, Puccianti E, Montagna MT, de Donno A, Susever S et al. Fundamental niche prediction of the pathogenic yeasts Cryptococcus neoformans and Cryptococcus gattii in Europe: Cryptococcus fundamental niche in Europe. Environ Microbiol 2017; 19:4318–4325
    [Google Scholar]
  27. Chowdhary A, Randhawa HS, Boekhout T, Hagen F, Klaassen CH et al. Temperate climate niche for Cryptococcus gattii in Northern Europe. Emerg Infect Dis 2012; 18:172–174 [View Article][PubMed]
    [Google Scholar]
  28. Colom MF, Hagen F, Gonzalez A, Mellado A, Morera N et al. Ceratonia siliqua (carob) trees as natural habitat and source of infection by Cryptococcus gattii in the Mediterranean environment. Med Mycol 2012; 50:67–73 [View Article][PubMed]
    [Google Scholar]
  29. Tintelnot K. Kryptokokkose: Cryptococcus gattii-infektionen können importiert werden und schwer verlaufen. Robert-Koch-Institut Epidemiologisches Bulletin 2008; 20:159
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.005168
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.005168
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error